Rejoyn Becomes First Prescription Digital Therapeutic Authorized for Treatment of MDD; The FDA has cleared the first prescription digital therapeutic for major depressive disorder, Rejoyn.

Media coverage

• Title	Rejoyn Becomes First Prescription Digital Therapeutic Authorized for Treatment of MDD; The FDA has cleared the first prescription digital therapeutic for major depressive disorder, Rejoyn.
  Media name/outlet	Psychiatric Times (MJH)
  Country/Territory	United States
  Date	1/04/24
  Persons	Brian Iacoviello